Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) FCF Margin (2020 - 2025)

Historic FCF Margin for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 2.93%.

  • Stemtech's FCF Margin rose 1164800.0% to 2.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.62%, marking a year-over-year decrease of 171500.0%. This contributed to the annual value of 11.9% for FY2024, which is 294700.0% up from last year.
  • Per Stemtech's latest filing, its FCF Margin stood at 2.93% for Q3 2025, which was up 1164800.0% from 10.74% recorded in Q2 2025.
  • In the past 5 years, Stemtech's FCF Margin ranged from a high of 73.59% in Q1 2024 and a low of 118.04% during Q4 2021
  • Its 5-year average for FCF Margin is 28.24%, with a median of 22.1% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 1243000bps in 2024, then plummeted by -1554500bps in 2025.
  • Stemtech's FCF Margin (Quarter) stood at 118.04% in 2021, then soared by 81bps to 22.3% in 2022, then dropped by -29bps to 28.72% in 2023, then rose by 28bps to 20.62% in 2024, then surged by 114bps to 2.93% in 2025.
  • Its FCF Margin was 2.93% in Q3 2025, compared to 10.74% in Q2 2025 and 81.85% in Q1 2025.